Microalbuminuria in chronic hepatitis B infection

Area of Science:

• Nephrology
• Hepatology
• Virology

Background:

• Chronic hepatitis B virus (HBV) infection is a global health concern.
• Renal complications, including microalbuminuria, are associated with HBV.
• Early detection of renal damage is crucial for patient management.

Purpose of the Study:

• To investigate microalbuminuria levels in patients with HBV infection.
• To evaluate the impact of antiviral treatment on microalbuminuria.
• To determine if microalbuminuria can serve as a marker for preclinical renal damage and treatment response.

Main Methods:

• A study involving four groups: inactive HBsAg carriers, chronic HBV patients responding to treatment, non-responding chronic HBV patients, and healthy controls.
• Measurement of microalbuminuria at baseline and follow-up points (3, 6, and 9 months).
• Comparison of microalbuminuria levels between groups and over time.

Main Results:

• Patients with chronic HBV infection (especially those responding to treatment) showed higher initial microalbuminuria levels compared to controls and inactive carriers.
• Microalbuminuria levels decreased significantly in patients who responded to antiviral treatment over 9 months.
• A significant difference in microalbuminuria was observed between responding and non-responding patients after treatment initiation.
• Initial microalbuminuria levels did not differ between responding and non-responding groups, but diverged significantly post-treatment.

Conclusions:

• Microalbuminuria is a potential indicator of preclinical renal damage in chronic HBV infection.
• Monitoring microalbuminuria can help assess the effectiveness of antiviral therapies like interferon and lamivudine in children with HBV.
• This marker may aid in personalized treatment strategies for HBV-associated kidney disease.